Zeel and the Ageing Joint: Antihomotoxic Support in Arthrosis

Part 5 of our series, ‘Understanding Homotoxicology.’

A creaking knee on the stairs, a hip that stiffens after sitting, fingers that ache in cold, damp weather — the worn joint tells its own quiet story. This is arthrosis: not the hot, dramatic swelling of an acute injury, but the slow deformation of a joint whose repair has fallen behind its wear.

In homotoxicology this places arthrosis in a very different part of the map from a sprain. Where Traumeel S answers the inflammatory reaction phase, the ageing, arthrotic joint has usually crossed into the degeneration phase — and calls for a different kind of remedy.

Zeel is Heel’s dedicated answer to that stage. Its design is unusually revealing, because it combines three quite distinct classes of ingredient — cartilage and suis-organ extracts, rheumatic botanicals, and metabolic catalysts — each aimed at a different aspect of the failing joint.

Arthrosis as a degeneration-phase process

Our article on the six-phase table describes how illness can move, over time, from active humoral reactions across the ‘biological division’ into the deeper cellular phases — deposition, impregnation and finally degeneration, where tissue structure itself is lost. Arthrosis is the joint’s expression of that later territory.

The compendium is exact about what has gone wrong at the tissue level:

‘In arthrosis, there is a pathological alteration of the metabolism of the connective tissue in the joint (cartilage, synovial membrane and also synovial fluid), characterized by increased degradation of the connective tissue structures. This results, therefore, in disproportion between catabolic and anabolic-metabolic processes.’ — Biotherapeutic Index, ‘Zeel’

From this the therapeutic aim follows directly: ‘the task of effective therapy is to normalize the disturbed metabolism, as well as offering components for possible incorporation’ (Biotherapeutic Index, ‘Zeel’). Zeel is built to do both at once — to supply raw materials and to restart the energy metabolism that lets the joint use them.

Rebuilding the raw materials: the suis-organ constituents

The first layer of the formula is a set of porcine (suis) organ extracts, prepared in potentised form and chosen to match the tissues under strain (Biotherapeutic Index, ‘Zeel’):

• Cartilago suis (cartilage) — for ‘arthrosis deformans, coxitis, periarthritis humeroscapularis’ — the constituent aimed squarely at the arthrodial cartilage itself.
• Funiculus umbilicalis suis (Wharton’s jelly of the umbilical cord) — for ‘damage to connective tissues, circulatory disorders.’
• Embryo suis — ‘for revitalization in the cellular phases’ — a general regenerative stimulus appropriate to degeneration.
• Placenta suis — for ‘circulatory disturbances’, improving the blood supply on which repair depends.

The rationale is stated plainly: ‘the organ constituents provide important components of the connective tissue (cartilage, funiculus umbilicalis), while placenta promotes the circulation and the embryo has an additional stimulating action.’ This is organ therapy in the service of structure — offering the joint the very components its metabolism is failing to make. We look more closely at how suis-organ preparations work in a later article on isopathy and organ therapy.

The botanical layer: rheumatic pain and the weather-worn joint

Layered onto the organ extracts is a group of classic rheumatic botanicals, which address the symptomatic face of arthrosis — the stiffness and pain, so often worse in cold and wet (Biotherapeutic Index, ‘Zeel’):

• Rhus toxicodendron — ‘rheumatism and neuralgia, worse in cold, wet weather; polyarthritis, diseases of the mucosa and connective tissues.’
• Arnica montana — ‘to stimulate the healing of wounds, rheumatism, injuries arising from falls, blows or contusions; pains in the back and limbs.’
• Solanum dulcamara (bittersweet) — the remedy ‘to counteract the effects of wet weather’ and its rheumatic aggravations.
• Symphytum officinale (comfrey) — ‘injuries to the tendons, ligaments and periosteum; acts on the joints in general, neuralgia of the knee.’
• Sanguinaria canadensis (blood-root) — ‘neuralgic and rheumatoid pains of the joints and muscles.’

As the compendium summarises, these botanicals ‘are applied for rheumatic diseases of the joints, etc., including when the disorders are worsened in wet weather’ — the familiar clinical picture of the arthrotic knee or shoulder that flares with a change in the weather.

The catalyst layer: restarting energy in the cartilage

The most distinctive part of Zeel is a set of cellular-energy catalysts: Nadidum (nicotinamide adenine dinucleotide), Coenzyme A, Acidum alpha-liponicum (thioctic acid) and Natrium diethyloxalaceticum (sodium oxalacetate). These are not symptomatic remedies at all — they are components of the citric acid cycle and respiratory chain.

The compendium’s reasoning is worth following. In healthy cartilage, lactate formed by glycolysis reaches the joint capsule, where ‘by stimulation of the end oxidation through the citric acid cycle, the necessary energy is released.’ Nadidum is ‘the starting member of the respiratory chain’ and catalyses the pivotal oxidoreduction ‘between lactic acid and pyruvic acid’; thioctic acid drives the ‘oxidative decarboxylation’ of pyruvate; Coenzyme A forms the ‘activated acetic acid’ that ‘initiates’ the cycle; and oxalacetate is described vividly ‘as the fuel, or also as the engine, of the citric acid cycle’ (Biotherapeutic Index, ‘Zeel’).

In other words, Zeel tries to relight the joint’s metabolic furnace so that the raw materials it also supplies can actually be built into tissue. This catalyst principle runs right through the Heel range; we devote a whole article to it in catalysts and cellular energy.

Sulphur, silica and the connective-tissue matrix

Two mineral constituents complete the picture. Sulfur is a ‘reagent in all chronic diseases’ whose ‘cellular activity is influenced catalytically’ — and the compendium notes that the body ‘can incorporate or convert the sulphur into chondroitin sulphates intrinsic to the body’, a direct contribution to cartilage matrix. Silicea (silicic acid), present in the tablets and ointment, addresses ‘weakness and impairment of the connective tissues; weakness of the ligaments’ (Biotherapeutic Index, ‘Zeel’).

Together the three layers make Zeel a compact model of antihomotoxic thinking for the degenerative joint: supply the components, ease the rheumatic reaction, and restore the energy metabolism that binds the two.

Using Zeel in practice

The Therapeutic Index lists Zeel as the lead remedy for ‘arthrosis (in particular gonarthrosis), polyarthrosis, spondylarthrosis’ and scapulohumeral periarthritis. In the entry for degenerative arthritis it is used as tablets three times daily, with the ointment ‘applied liberally to affected joints’ — often overnight under a dressing — and, in practitioner hands, as periarticular injections (Biotherapeutic Index, ‘Arthritis (degenerative or osteoarthritis)’).

Because so many worn joints also flare, the compendium pairs Zeel with Traumeel whenever an inflammatory component is present: ‘some cases of osteoarthritis also have an inflammatory component and Traumeel S may be useful in addition’. Where the underlying problem is a sluggish, energy-starved metabolism, it may be reinforced by the deeper catalyst preparations — Coenzyme compositum, Ubichinon compositum and, for the circulation that feeds the joint, Cor compositum, itself built around suis-organ extracts and citric-acid-cycle acids.

---

Featured remedies from this article

The preparations discussed above are all available to explore:

Source: All quotations, compositions and definitions are drawn from the Heel Biotherapeutic Index — Ordinatio Antihomotoxica et Materia Medica, 5th revised English edition (Biologische Heilmittel Heel GmbH, Baden-Baden, 2000): the Pharmacological Index monographs ‘Zeel’ (composition, per-constituent pharmacological notes and the arthrosis/citric-acid-cycle rationale) and ‘Cor compositum’, and the Therapeutic Index entry ‘Arthritis (degenerative or osteoarthritis)’.